-
-
-
-
-
-
-
Biogen (BIIB) PT Raised to $260 at RBC Capital, 'Deep Dive Suggests Upcoming Liti SLE Data Could Start I&I Buildout On Right Path'
-
-
-
-
-
-
-
Biogen (BIIB) PT Raised to $248 at Canaccord
-
-
-
-
-
-
-
Real-world Leqembi study shows 82% of Alzheimer's patients stable
-
-
-
-
-
-
-
Biogen (BIIB) Reiterated at Overweight by Cantor Fitzgerald: Advancing with BIIB080
-
-
-
-
-
-
-
Evercore ISI Reinstates Biogen (BIIB) at Outperform
-
-
-
-
-
-
-
Bright Horizons Family Solutions and Remitly Global to Join S&P SmallCap 600
-
-
-
-
-
-
-
Biogen (BIIB) PT Raised to $260 at Guggenheim
-
461,057 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

